Biodesix (BDSX) Total Liabilities (2019 - 2026)

Biodesix (BDSX) has reported Total Liabilities for 8 consecutive years, with $85.5 million the latest figure, recorded in Q1 2026.

• Total Liabilities for Q1 2026 came in at $85.5 million, up 13.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $85.5 million (up 13.73% YoY), and the FY2025 annual result was $89.9 million, up 17.77% from the prior year.
• Total Liabilities was $85.5 million for Q1 2026 at Biodesix, down from $89.9 million in the prior quarter.
• Over five years, Total Liabilities peaked at $94.5 million in Q4 2023 and troughed at $53.9 million in Q1 2022.
• Average Total Liabilities over 5 years is $79.7 million, with a median of $79.6 million recorded in 2024.
• Year-over-year, Total Liabilities sank 31.86% in 2022 and jumped 41.53% in 2023.
• Over 5 years, Total Liabilities stood at $72.3 million in 2022, then jumped by 30.73% to $94.5 million in 2023, then dropped by 19.2% to $76.4 million in 2024, then climbed by 17.77% to $89.9 million in 2025, then retreated by 4.93% to $85.5 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $85.5 million in Q1 2026, $89.9 million in Q4 2025, and $90.4 million in Q3 2025.